Back to UBS Group AG UBS Group AG

MBXMBX
7 quarters

Position history for UBS Group AGUBS Group AG's holdings in MBX Biosciences, Inc.

UBS Group AG holds 272,747 shares of MBX (MBX Biosciences, Inc.), worth $15.1M as of 2026-Q2. The position was decreased (-21.4% shares). MBX represents 0.0% of UBS Group AG's portfolio.

Current Value

$15.1M

Current Shares

272,747

Total Value Change

+$14.2M

Total Shares Change

+226,846

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
272,747
-21.4%
$15.1M0.0%$55.20
0
2026-Q1
Increased
346,914
+23.4%
$10.4M0.0%$30.54
34
2025-Q4
Increased
281,212
+363.1%
$8.9M0.0%$30.90
44
2025-Q3
Increased
60,725
+96.1%
$1.1M0.0%$17.94
40
2025-Q2
Increased
30,967
+12.6%
$353,3330.0%$10.75
27
2025-Q1
Decreased
27,499
-40.1%
$202,9430.0%$7.76
0
2024-Q4
New
45,901
-
$845,9550.0%$17.91
34

Other major holders of MBX: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used